Literature DB >> 27180276

Roles of extracellular nucleotides and P2 receptors in ectodomain shedding.

Aleta Pupovac1,2,3,4, Ronald Sluyter5,6,7.   

Abstract

Ectodomain shedding of integral membrane receptors results in the release of soluble molecules and modification of the transmembrane portions to mediate or modulate extracellular and intracellular signalling. Ectodomain shedding is stimulated by a variety of mechanisms, including the activation of P2 receptors by extracellular nucleotides. This review describes in detail the roles of extracellular nucleotides and P2 receptors in the shedding of various cell surface molecules, including amyloid precursor protein, CD23, CD62L, and members of the epidermal growth factor, immunoglobulin and tumour necrosis factor families. This review discusses the mechanisms involved in P2 receptor-mediated shedding, demonstrating central roles for the P2 receptors, P2X7 and P2Y2, and the sheddases, ADAM10 and ADAM17, in this process in a number of cell types.

Entities:  

Keywords:  Extracellular ATP; Extracellular UTP; Metalloprotease; P2X receptors; P2Y receptors; Purinergic signalling

Mesh:

Substances:

Year:  2016        PMID: 27180276     DOI: 10.1007/s00018-016-2274-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  111 in total

1.  Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.

Authors:  Aleta Pupovac; Nicholas J Geraghty; Debbie Watson; Ronald Sluyter
Journal:  Immunol Cell Biol       Date:  2014-08-26       Impact factor: 5.126

Review 2.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

3.  P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing.

Authors:  Jean M Camden; Ann M Schrader; Ryan E Camden; Fernando A González; Laurie Erb; Cheikh I Seye; Gary A Weisman
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

4.  CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.

Authors:  A Pupovac; L Stokes; R Sluyter
Journal:  Purinergic Signal       Date:  2013-06-21       Impact factor: 3.765

5.  P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.

Authors:  Ivan Milenkovic; Michael Weick; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

6.  CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.

Authors:  Christian Krebs; Sahil Adriouch; Fenja Braasch; Wolfgang Koestner; Edward H Leiter; Michel Seman; Frances E Lund; Norman Oppenheimer; Friedrich Haag; Friedrich Koch-Nolte
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

7.  P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes.

Authors:  Fred Aswad; Gunther Dennert
Journal:  Cell Immunol       Date:  2007-02-06       Impact factor: 4.868

8.  Major histocompatibility complex class I shedding and programmed cell death stimulated through the proinflammatory P2X7 receptor: a candidate susceptibility gene for NOD diabetes.

Authors:  James I Elliott; Christopher F Higgins
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

9.  Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

Authors:  J Arribas; L Coodly; P Vollmer; T K Kishimoto; S Rose-John; J Massagué
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

10.  Alternative splicing of the N-terminal cytosolic and transmembrane domains of P2X7 controls gating of the ion channel by ADP-ribosylation.

Authors:  Nicole Schwarz; Laurent Drouot; Annette Nicke; Ralf Fliegert; Olivier Boyer; Andreas H Guse; Friedrich Haag; Sahil Adriouch; Friedrich Koch-Nolte
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  10 in total

Review 1.  P2X7 as a scavenger receptor for innate phagocytosis in the brain.

Authors:  Ben J Gu; James S Wiley
Journal:  Br J Pharmacol       Date:  2018-10-05       Impact factor: 8.739

2.  Visualizing P2X7-Dependent Inflammasome Formation in Human Monocytes by Fluorescence Microscopy and Flow Cytometry.

Authors:  Samantha Eiberg; Leif Ancker; Sana Javed; Friedrich Haag
Journal:  Methods Mol Biol       Date:  2022

3.  Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function.

Authors:  Sinje Leitzke; Jana Seidel; Björn Ahrens; Rainer Schreiber; Karl Kunzelmann; Maria Sperrhacke; Sucharit Bhakdi; Karina Reiss
Journal:  Membranes (Basel)       Date:  2022-01-20

4.  ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.

Authors:  Marlies Sachs; Sebastian Wetzel; Julia Reichelt; Wiebke Sachs; Lisa Schebsdat; Stephanie Zielinski; Lisa Seipold; Lukas Heintz; Stephan A Müller; Oliver Kretz; Maja Lindenmeyer; Thorsten Wiech; Tobias B Huber; Renate Lüllmann-Rauch; Stefan F Lichtenthaler; Paul Saftig; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2021-03-30       Impact factor: 14.978

Review 5.  To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?

Authors:  Leanne Stokes; Stefan Bidula; Lučka Bibič; Elizabeth Allum
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

6.  High glucose inhibits osteogenic differentiation and proliferation of MC3T3‑E1 cells by regulating P2X7.

Authors:  Jinsan Yang; Cao Ma; Maoshu Zhang
Journal:  Mol Med Rep       Date:  2019-10-31       Impact factor: 2.952

7.  ADAM10 sheddase activation is controlled by cell membrane asymmetry.

Authors:  Florian Bleibaum; Anselm Sommer; Martin Veit; Björn Rabe; Jörg Andrä; Karl Kunzelmann; Christian Nehls; Wilmar Correa; Thomas Gutsmann; Joachim Grötzinger; Sucharit Bhakdi; Karina Reiss
Journal:  J Mol Cell Biol       Date:  2019-12-23       Impact factor: 6.216

Review 8.  Scramblases as Regulators of Proteolytic ADAM Function.

Authors:  Karina Reiss; Sinje Leitzke; Jana Seidel; Maria Sperrhacke; Sucharit Bhakdi
Journal:  Membranes (Basel)       Date:  2022-02-04

9.  6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist.

Authors:  Peter Cuthbertson; Amal Elhage; Dena Al-Rifai; Reece A Sophocleous; Ross J Turner; Ashraf Aboelela; Hiwa Majed; Richard S Bujaroski; Iman Jalilian; Michael J Kelso; Debbie Watson; Benjamin J Buckley; Ronald Sluyter
Journal:  Biomolecules       Date:  2022-09-16

Review 10.  Control of Macrophage Inflammation by P2Y Purinergic Receptors.

Authors:  Dominik Klaver; Martin Thurnher
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.